SureTrader Nadex Advertisement PGUS
Home > Boards > US OTC > Biotechs >

Aequus Pharmaceuticals (AQSZF)

AQSZF RSS Feed
Add AQSZF Price Alert      Hide Sticky   Hide Intro
Moderator: BioSpecialist
Search This Board: 
Last Post: 3/22/2017 2:36:37 AM - Followers: 8 - Board type: Free - Posts Today: 1

AQSZF (MC US$ 15M) 2 Marketed Drugs + 3 close to Approval including a Potential Blockbuster = SUPER LIFETIME OPPORTUNITY !!!!

This undiscovered low float rocket is definitely the cheapest Biotech Gem you can get at this time. This Stock has 10 bagger Potential easily with all the Big Drugs close to Market entry .Get some of this Goldmine before she gets discovered .Management alone holding over 16 Million shares Ceo bought 840k shares at 0.30 just a few days ago .GLTA

Update March 9, 2017
Aequus Pharma (AQS.V) (AQSZF)

Market-Cap: c$20.5 Million (US$15.15 Million)
Cash: c$5.1 Million << enough untill mid 2018
Price: $0.22

Shares out: 69 Million

Presentation November 2016

http://www.aequuspharma.ca/Investors/AQS%20investor%20November%202016_web.pdf

UPCOMING MILESTONE :

AQS1301 topline results in 1Q 2017

Operational profitability estimated in 2017

File for CDN approval of Topiramate XR in 1H 2017

File for CDN approval of Oxcarbazepine XR in 1H 2017

Additional Product acquisitions in 2017

Partnership for AQS1301 in 2017

Two products launches to date (Tacrolimus IR and Vistitan™)

3 long-acting, transdermal programs in development, on track to file NDA in 2018



Great Video
https://www.youtube.com/watch?v=jV00WmYBtv4

Marketed Products:

Tacrolimus IR : Aequus initiated promotional efforts for tacrolimus IR in December, 2015 •Tacrolimus products currently account for ~30% of a $300 million immunosuppressive market in Canada •Aequus is promoting the first to market generic version of Prograf (tacrolimus IR)

Vistitan : Aequus initiated commercial activities in Q2 2016 for Vistitan (bimatoprost 0.03%) •The Canadian glaucoma market in 2014 was estimated to be over $137 million, of which prostaglandins remain one of the primary treatment options.

Topiramate XR (Epilepsy and Migraine) NDS submission to Health Canada in 1Q 2017

Oxcarbazepine XR (Epilepsy) NDS submission to Health Canada in 1Q 2017


NDA Filing for AQS-1301:Expected 3Q2017 Expected Commercial License (If Bioequivalence demonstrated in Phase I, Registration Study may NOT be required for Approval of AQS1301)

AQS-1301, a transdermal aripiprazole product candidate in development for potential weekly use in the treatment of irritability associated with autistic disorder, bipolar I disorder, schizophrenia and major depressive disorder. The currently available dosage forms of aripiprazole (sold primarily under the trade name Abilify®) reached total worldwide sales of over $8 billion USD in 2014. A once-weekly transdermal patch has the potential to improve medication adherence and reduce the frequency of relapse.




Podcast: Aequus Pharmaceuticals CEO Doug Janzen on the low cost of drug commercialization in Canada
http://business.financialpost.com/midas-letter/podcast-aequus-pharmaceuticals-ceo-doug-janzen-on-the-low-cost-of-drug-commercialization-in-canada

James West: Sure. Have you built a pharmaceutical company before, Doug?

Doug Janzen: I have. So I’ve been in this industry for 20 years. I was a banker, then I ran a therapeutic company called Cardiome Pharma; I built that from 50 million to over 1 billion at its peak, and exited after doing an $800 million license with Merck — still the largest license transaction in Canadian history.

James West: Sure. Let me ask that another way: how do you plan to get to – I mean, how many of these deals can you do a year?

Doug Janzen: We bought our commercial infrastructure last July, and since then we’ve launched two products and we’ve just licensed the two Supernus programs. Those four products, we think an aggregate can do $40 million, $45 million at peak sales.




  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AQSZF
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#69  Sticky Note Mcap $15M/ Cash till mid 2018/ HUGE Pipeline BioSpecialist 03/14/17 01:23:12 PM
#86   I AGREE. chakalalaBoom 03/22/17 02:36:37 AM
#85   Huge buys coming in. Poised to run scotsand 03/20/17 10:13:09 AM
#83   AQS1301 Topline Results within 10 days = Push BioSpecialist 03/17/17 01:23:56 PM
#82   Nice buys coming in now scotsand 03/16/17 11:14:17 AM
#81   Need volume, hidden gem here. scotsand 03/16/17 10:45:05 AM
#80   Looking good indeed scotsand 03/15/17 12:18:07 PM
#79   Moving up now > .221 X .236 ... molee 03/15/17 10:39:09 AM
#78   Nice bid support this morning...could jump to upper scotsand 03/15/17 09:54:59 AM
#77   main listing is AQS.V on TSX-V Canada BioSpecialist 03/15/17 09:40:39 AM
#76   C'mon man .. I just posted they are molee 03/15/17 09:23:26 AM
#75   Anyone know for sure? I want to yman 03/15/17 09:21:01 AM
#74   Well , they are wrong ... YES ? molee 03/15/17 09:18:11 AM
#73   My scottrade account shows listed on the grey yman 03/15/17 09:13:33 AM
#72   Ummm excuse me ? ... http://www.otcmarkets.com/stock/AQSZF/profile molee 03/15/17 09:07:00 AM
#71   Why on the grey sheets list? yman 03/15/17 08:59:38 AM
#70   Volume up a bit.. This one could move scotsand 03/14/17 04:11:45 PM
#69   Mcap $15M/ Cash till mid 2018/ HUGE Pipeline BioSpecialist 03/14/17 01:23:12 PM
#67   We need to add the newly issued shares WallStPirate 03/14/17 12:57:54 PM
#66   investorshub.advfn.com/uimage/uploads/2017/3/14/it[zeAQSZF.JPG molee 03/14/17 12:50:31 PM
#65   Otcmarket.com stated.. chakalalaBoom 03/14/17 12:50:05 PM
#64   I do not understand your post unlimited? WallStPirate 03/14/17 12:44:33 PM
#63   ( LONGS ) chakalalaBoom 03/14/17 12:25:21 PM
#62   I agree.. chakalalaBoom 03/14/17 11:49:49 AM
#61   I picked up a starter yesterday ... molee 03/14/17 09:13:51 AM
#60   Quiet board here.. scotsand 03/14/17 09:09:12 AM
#59   Been watching awhile, grabbed some today. GLTA scotsand 03/13/17 11:18:57 AM
#57   News out scotsand 03/13/17 10:18:08 AM
#56   Look at SUPN and what they did with WallStPirate 03/13/17 08:20:51 AM
#55   Been following for some time got in Mayish mh22 03/12/17 09:42:35 PM
#54   AQS1301 topline results imminent(this month) BioSpecialist 03/08/17 02:56:11 PM
#53   Wrong stock I bought this at .22 today WallStPirate 03/07/17 03:50:33 PM
#52   Got some yesterday and today some more @ WallStPirate 03/07/17 02:59:38 PM
#51   I just watched the video which answered my WallStPirate 03/05/17 06:56:31 PM
#50   Does anyone know what the total market size WallStPirate 03/05/17 09:16:58 AM
#49   Just FOUND out about AQSZF. chakalalaBoom 03/03/17 03:36:29 PM
#48   MC $20M /MEGA Pipeline /Close to Profitability /Cash BioSpecialist 03/03/17 03:35:46 PM
#46   Great News out today ..Cannabinoid Patch =HUGE Potential BioSpecialist 03/02/17 08:35:49 AM
#45   Great Video out today BioSpecialist 02/15/17 08:58:42 AM
#44   Ceo said there will be new Deals this BioSpecialist 01/20/17 09:30:06 AM
#43   volume creep...= news leak? or just speculation geoart9 01/19/17 07:03:00 PM
#42   Possible buyout in the making here BioSpecialist 01/19/17 03:34:38 PM
#41   How much cash do they have? Rymankoly 01/12/17 11:17:26 AM
#40   picked up a small starter here..glta geoart9 01/12/17 11:01:54 AM
#38   AQSZF is close to profitability and to file BioSpecialist 01/11/17 01:41:18 PM
#37   Got a great Reply by Ceo Janzen ..this BioSpecialist 01/11/17 12:02:48 PM
#36   hey fella, where did you go? stock is tanking ronpopeil 11/17/16 03:52:38 PM
#35   where did you go pumper? stock getting destroyed. ronpopeil 11/16/16 10:26:45 AM
#34   Where did you go Mr. Pumper/Dumper? ronpopeil 11/02/16 12:14:28 PM
#33   News out. I know most of you sold ronpopeil 10/17/16 11:47:09 AM
#32   Looks like the pump is over. Pumpers moving ronpopeil 10/10/16 12:00:34 PM
PostSubject